Oncology
🇺🇸 FDA Page 15FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 169–180 of 246 articles
IceCure Medical ProSense Revenue Surges 30% in Q1 2026 as Cryoablation Technology Gains Traction
Nuvalent to Present Pivotal Neladalkib Data from ALKOVE-1 Trial at ASCO 2026 for ALK-Positive Lung Cancer
FDA Approval of Viruxa: Market Analysis and Clinical Review for Advanced Melanoma
FDA Guidance on Oncology Drugs: Impact on Accelerated Approval Pathways
FDA Real-World Evidence: Evolving Regulatory Framework and Market Impact
Brazilian Oncology Market: Growth of Precision Medicine & Biomarker Testing
SFDA Accelerated Approval Pathway: Enhancing Oncology Drug Access in Saudi Arabia
GCC Oncology Guidelines: Impact on Treatment Standardization & Drug Selection
Small Molecule vs Biologics in Oncology: Market Trends & FDA Insights 2024
FDA Accelerated Approval Oncology: 5-Year Impact Assessment
Sapience Therapeutics ST316 Shows 47% Response Rate in Phase 2 Colorectal Cancer Trial
Abogen's ABO2203 mRNA Cancer Therapy Shows Promise in First-in-Human B-Cell Lymphoma Trial at AACR 2026